Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Placing CF2 in the Center: Major Physicochemical Changes Upon a Minor Structural Alteration in Gem-Difunctional Compounds.
Saphier S, Katalan S, Yacov G, Berliner A, Redy-Keisar O, Fridkin G, Ghindes-Azaria L, Columbus I, Pevzner A, Drug E, Prihed H, Gershonov E, Eichen Y, Elias S, Parvari G, Zafrani Y. Saphier S, et al. Among authors: berliner a. Chemistry. 2023 Feb 1;29(7):e202202939. doi: 10.1002/chem.202202939. Epub 2022 Dec 12. Chemistry. 2023. PMID: 36374157
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
Brown DM, Boyer DS, Do DV, Wykoff CC, Sakamoto T, Win P, Joshi S, Salehi-Had H, Seres A, Berliner AJ, Leal S, Vitti R, Chu KW, Reed K, Rao R, Cheng Y, Sun W, Voronca D, Bhore R, Schmidt-Ott U, Schmelter T, Schulze A, Zhang X, Hirshberg B, Yancopoulos GD, Sivaprasad S; PHOTON Investigators. Brown DM, et al. Among authors: berliner aj. Lancet. 2024 Mar 23;403(10432):1153-1163. doi: 10.1016/S0140-6736(23)02577-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461843 Clinical Trial.
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial.
Lanzetta P, Korobelnik JF, Heier JS, Leal S, Holz FG, Clark WL, Eichenbaum D, Iida T, Xiaodong S, Berliner AJ, Schulze A, Schmelter T, Schmidt-Ott U, Zhang X, Vitti R, Chu KW, Reed K, Rao R, Bhore R, Cheng Y, Sun W, Hirshberg B, Yancopoulos GD, Wong TY; PULSAR Investigators. Lanzetta P, et al. Among authors: berliner aj. Lancet. 2024 Mar 23;403(10432):1141-1152. doi: 10.1016/S0140-6736(24)00063-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461841 Clinical Trial.
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial.
Wykoff CC, Brown DM, Reed K, Berliner AJ, Gerstenblith AT, Breazna A, Abraham P, Fein JG, Chu KW, Clark WL, Leal S, Schmelter T, Hirshberg B, Yancopoulos GD, Vitti R; CANDELA Study Investigators. Wykoff CC, et al. Among authors: berliner aj. JAMA Ophthalmol. 2023 Sep 1;141(9):834-842. doi: 10.1001/jamaophthalmol.2023.2421. JAMA Ophthalmol. 2023. PMID: 37535382
Radioactive contamination in feral dogs in the Chernobyl exclusion zone: Population body-burden survey and implications for human radiation exposure.
Hecla J, Kambarian E, Tubbs R, McKinley C, Berliner AJ, Russell K, Spatola G, Chertok J, Braun W, Hank N, Marquette C, Betz J, Paik T, Chenery M, Cagan A, Willis C, Mousseau T. Hecla J, et al. Among authors: berliner aj. PLoS One. 2023 Jul 20;18(7):e0283206. doi: 10.1371/journal.pone.0283206. eCollection 2023. PLoS One. 2023. PMID: 37471331 Free PMC article.
Microbial biomanufacturing for space-exploration-what to take and when to make.
Averesch NJH, Berliner AJ, Nangle SN, Zezulka S, Vengerova GL, Ho D, Casale CA, Lehner BAE, Snyder JE, Clark KB, Dartnell LR, Criddle CS, Arkin AP. Averesch NJH, et al. Among authors: berliner aj. Nat Commun. 2023 Apr 21;14(1):2311. doi: 10.1038/s41467-023-37910-1. Nat Commun. 2023. PMID: 37085475 Free PMC article. Review.
136 results